The Guardian
Email YouTube Facebook Instagram Twitter
 
Science & Tech

Why exact science made the $2.8 Billion deal for genomic

By Bloomberg
31 Jul 2019   |   11:11 am   |  
Kevin Conroy, Exact Sciences Corp. chairman and chief executive officer, discusses the company's $2.8 billion purchase of Genomic Health.


Share:

You may also like